Malgorzata Firczuk

11PUBLICATIONS
36CO-AUTHORS
Haematological tumoursTumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 20, 2026
mTORC1 inhibition upregulates CD20 and enhances anti-CD20 antibody efficacy in B-cell precursor acute lymphoblastic leukemia.

|Apr 04, 2025
LILRB1-directed CAR-T cells for the treatment of hematological malignancies.

Katsiaryna Marhelava, Klaudyna Fidyt, Monika Pepek

|Jul 27, 2022
Immune Evasion as the Main Challenge for Immunotherapy of Cancer.

Radoslaw Zagozdzon, Magdalena Winiarska, Malgorzata Firczuk

|Jun 10, 2022
CAR-T Cells Shoot for New Targets: Novel Approaches to Boost Adoptive Cell Therapy for B Cell-Derived Malignancies.

Katsiaryna Marhelava, Marta Krawczyk, Malgorzata Firczuk

|Jan 29, 2022
Potent, p53-independent induction of NOXA sensitizes MLL-rearranged B-cell acute lymphoblastic leukemia cells to venetoclax.

Klaudyna Fidyt, Agata Pastorczak, Julia Cyran

|Dec 02, 2021
PRDX-1 Supports the Survival and Antitumor Activity of Primary and CAR-Modified NK Cells under Oxidative Stress.

Marta Klopotowska, Malgorzata Bajor, Agnieszka Graczyk-Jarzynka

Pageof 2

Frequent Collaborators

3 joint publications

Martyna Poprzeczko

2 joint publications

Malgorzata Bajor

2 joint publications

Agnieszka Graczyk-Jarzynka

2 joint publications

Radoslaw Zagozdzon